Washington, DC–(ENEWSPF)–September 29, 2015. A monoclonal antibody therapeutic drug, a novel approach to treating patients with influenza, will advance in development with funding from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR).
No monoclonal antibody antiviral drugs to treat patients with influenza have been approved by the U.S. Food and Drug Administration. Monoclonal antibodies bind to specific parts of the virus, neutralizing…
